Business Wire
-
Thermo Fisher Scientific Launches New ENERGY STAR Certified TSX Universal Series ULT Freezers To Deliver Tighter Temperature Control And Faster Recovery Times
4/8/2024
Building on 80 years of expertise engineering cold storage lab equipment, Thermo Fisher Scientific today introduces its newest line of high performance, ultra-low temperature (ULT) freezers.
-
Nucleai And GoPath Diagnostics Announce Strategic Collaboration To Provide Integrated AI-Powered Digital Pathology Solutions For Clinical Research And Diagnostic Applications
4/8/2024
Nucleai, a spatial AI biomarker company that deciphers cellular conversations and maps cellular interactions within tissue samples to predict therapeutic outcomes, today announced a strategic collaboration with GoPath Diagnostics, a leading full-service digital pathology and molecular diagnostics laboratory.
-
Sebia Receives U.S. FDA Clearance For The CAPILLARYS 3 DBS Devices
4/5/2024
Sebia, a global specialty diagnostic company providing innovative solutions for screening and diagnostics in oncology, metabolic diseases, genetic disorders and autoimmune diseases, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for CAPILLARYS 3 DBS devices.
-
Descartes Labs Accelerates Growth With Strategic Acquisition Of Geosite
4/2/2024
Descartes Labs, a leading provider of geospatial analytics and artificial intelligence solutions, announced today that it acquired all of the operating assets of Geosite, a SaaS provider of geospatial intelligence to property and casualty insurance companies.
-
Agilent Launches New Advanced Dilution System To Increase Lab Efficiency
4/1/2024
Agilent Technologies Inc. today announced the launch of the Advanced Dilution System, the ADS 2, a new automation workflow solution that will increase productivity, lower cost of ownership, and improve the overall efficiency within the laboratory.
-
Grace Health Technology Launches New Laboratory Management Software
3/29/2024
Grace Health Technology, a leading provider of innovative software solutions for the healthcare industry, today announced the expansion of its laboratory-specific applications with the launch of a groundbreaking new application poised to revolutionize laboratory technology and enhance efficiency in healthcare settings.
-
Bostongene Recognized As Designated Laboratory For The ComboMATCH Precision Medicine Clinical Trial
3/26/2024
BostonGene, a leading provider of AI-driven, molecular and immune profiling solutions, today announced its participation in the Molecular Analysis for Combination Therapy Choice (ComboMATCH) precision medicine initiative as a designated laboratory.
-
STEMCELL Technologies Announces FDA De Novo Classification For Its EasySep CD138 Positive Selection Kit To Support Cancer Diagnostic Tests
3/26/2024
STEMCELL Technologies is pleased to announce that its new EasySep Human Bone Marrow CD138 Positive Selection Kit has been granted de novo classification by the U.S. Food and Drug Administration (FDA) as a first-of-its-kind in vitro diagnostic (IVD) medical device for hematopoietic cell enrichment.
-
Nucleus Genomics Launches To Bring Whole-Genome Sequencing To The Public
3/25/2024
Nucleus Genomics, the next-generation genetic testing and analysis company, today announced the launch of its DNA analysis product to bring the benefits of personalized medicine to everyone.
-
CMS Designates The NavDx Test As An Advanced Diagnostic Laboratory Test (ADLT)
3/21/2024
Naveris, Inc., the leader in precision oncology diagnostics for viral-related cancers, today announced that the Centers for Medicare & Medicaid Services (CMS) has designated NavDx, the Tumor Tissue Modified Viral (TTMV)-HPV DNA blood test that aids in the detection of HPV-driven cancer, as an Advanced Diagnostic Laboratory Test (ADLT).